Clinical trial
Long-Term Olanzapine Treatment in Children With Autism
NCT00183404 · Drexel University, Other · Completed
Key facts
| NCT number | NCT00183404 |
|---|---|
| Title | Long-Term Olanzapine Treatment in Children With Autism |
| Official title | Long-Term Olanzapine Treatment in Children With Autism |
| Lead sponsor | Drexel University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | Olanzapine |
| Enrollment | 32 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: